Action INSM INSMED INCORPORATED
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Communiqués Insmed Incorporated

Actions

INSM

US4576693075

Temps réel estimé Cboe BZX
Autres places de cotation
 18:25:42 17/07/2024 		Varia. 5j. Varia. 1 janv.
75,3 USD -3,44 % Graphique intraday de Insmed Incorporated +2,85 % +142,59 %
03/07 Insmed présente cette semaine d'autres données positives concernant un traitement médicamenteux prospectif de la bronchectasie MT
03/07 Insmed Incorporated annonce de nouveaux résultats positifs de l'étude ASPEN CI

Communiqués

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Insmed Reports Inducement Grants under NASDAQ Listing Rule 5635(4)
AQ
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR
Insmed - Additional Positive Data from Pivotal ASPEN Study of Brensocatib in Patients with Bronchiectasis to be presented at the 7th World Bronchiectasis Conference
AQ
Additional Positive Data from Pivotal ASPEN Study of Brensocatib in Patients with Bronchiectasis to be Presented at the 7th World Bronchiectasis Conference
PR
Insmed Announces Redemption of all $225 Million of Outstanding 1.75% Convertible Senior Notes Due 2025
PR
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR
Insmed To Present at the Goldman Sachs 45th Annual Global Healthcare Conference
PR
Insmed to Host Commercial Webinar on June 4, 2024
PR
Insmed Announces Pricing of $650 Million Public Offering of Common Stock
PR
Insmed Announces Proposed $500 Million Public Offering of Common Stock
PR
Insmed, Agios rise; DraftKings, Atlantica fall, Tuesday, 5/28/2024
AQ
Insmed Announces Positive Topline Results from Landmark ASPEN Study of Brensocatib in Patients with Bronchiectasis
PR
Insmed to Host Investor Call to Discuss Topline Results from Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis
PR
Insmed Reports First-Quarter 2024 Financial Results and Provides Business Update
AQ
Insmed: Q1 Earnings Snapshot
AQ
Insmed To Present at the BofA Securities Health Care Conference 2024
PR
Insmed Reports Inducement Grants under NASDAQ Listing Rule 5635(4)
AQ
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR
Insmed to Host First-Quarter 2024 Financial Results Conference Call on Thursday, May 9, 2024
PR
Insmed Reports Inducement Grants under NASDAQ Listing Rule 5635(4)
AQ
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action INSM
  4. Actualités Insmed Incorporated
  5. Communiqués